Showing results (1311-1320 of 1,344) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|March 4, 2015
Common variants of the G protein-coupled receptor type 4 are associated with human essential hypertension and predict the blood pressure response to angiotensin receptor blockadeH Sanada, M Yoneda, J Yatabe, et al.
The Pharmacogenomics Journal|March 18, 2015
Genetic modifiers of response to glucose-insulin-potassium (GIK) infusion in acute coronary syndromes and associations with clinical outcomes in the IMMEDIATE trialK L Ellis, Y Zhou, J R Beshansky, et al.
The Pharmacogenomics Journal|March 18, 2015
Impact of genetic variants of RFC1, DHFR and MTHFR in osteosarcoma patients treated with high-dose methotrexateS Jabeen, L Holmboe, G I G Alnæs, et al.
The Pharmacogenomics Journal|April 1, 2015
The role of Toll-like receptor 4 polymorphisms in vaccine immune responseP Pellegrino, F S Falvella, S Cheli, et al.
The Pharmacogenomics Journal|March 11, 2015
Tag SNPs for HLA-B alleles that are associated with drug response and disease risk in the Chinese Han populationX Liu, J Sun, H Yu, et al.
The Pharmacogenomics Journal|April 8, 2015
A prospective randomized evaluation of a pharmacogenomic approach to antiplatelet therapy among patients with ST-elevation myocardial infarction: the RAPID STEMI studyD Y F So, G A Wells, R McPherson, et al.
The Pharmacogenomics Journal|September 26, 2012
VEGF genetic polymorphisms affect the responsiveness to sildenafil in clinical and postoperative erectile dysfunctionR Lacchini, J J Muniz, Y T D A Nobre, et al.
The Pharmacogenomics Journal|June 27, 2012
Can population differences in chemotherapy outcomes be inferred from differences in pharmacogenetic frequencies?M Loh, D Chua, Y Yao, et al.
The Pharmacogenomics Journal|June 20, 2012
Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosisE Croze, K D Yamaguchi, V Knappertz, et al.
The Pharmacogenomics Journal|March 24, 2010
Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention TrialD Serrano, M Lazzeroni, C-F Zambon, et al.
Pageof 135